Skip to content
StockMarketAgent

Best profitable small-cap stocks for 2026: positive net income, ROE 12+

Most small-cap screens surface unprofitable hopefuls. The cohort below inverts that — small-cap names ($300M to $2B market cap) that are already profitable, generating real returns on equity, and carrying enough current assets to weather a downturn. This is the small-cap subset that institutional investors actually hold. Each name still carries small-cap volatility and liquidity risk, so the position-sizing rules in each ticker's full report (covered in the per-stock /risks tab) become more important than usual.

How we picked: Cohort: market cap between $300M and $2B, positive net income, ROE at least 12%, current ratio at least 1.5. Sorted by market cap descending.

Source snapshot 2026-08-08 · freshness SLO 72 hours.

  1. 01
    TGLSTecnoglass Holdings Inc.

    ROE 17.0% with a current ratio of 1.9 on Materials exposure.

    1.96B USD
  2. 02
    LPGDorian LPG Ltd.

    ROE 28.3% with a current ratio of 3.3 on Energy exposure.

    1.96B USD
  3. 03
    CHAChagee Holdings Limited

    ROE 15.3% with a current ratio of 3.4 on Consumer Discretionary exposure.

    1.94B CNY
  4. 04
    ATEXAnterix Inc.

    ROE 43.3% with a current ratio of 3.3 on Communication Services exposure.

    1.94B USD
  5. 05
    EPACEnerpac Tool Group Corp.

    ROE 21.6% with a current ratio of 2.7 on Industrials exposure.

    1.93B USD
  6. 06
    PLABPhotronics, Inc.

    ROE 13.2% with a current ratio of 5.0 on Technology exposure.

    1.93B USD
  7. 07
    GCTGigaCloud Technology Inc.

    ROE 32.3% with a current ratio of 2.1 on Technology exposure.

    1.90B USD
  8. 08
    CTSCTS Corporation

    ROE 12.4% with a current ratio of 2.6 on Technology exposure.

    1.89B USD
  9. 09
    LMATLeMaitre Vascular, Inc.

    ROE 16.8% with a current ratio of 16.3 on Healthcare exposure.

    1.86B USD
  10. 10
    SONOSonos, Inc.

    ROE 14.2% with a current ratio of 1.6 on Technology exposure.

    1.85B USD
  11. 11
    EVTCEVERTEC, Inc.

    ROE 14.8% with a current ratio of 1.7 on Technology exposure.

    1.78B USD
  12. 12
    LKFTLakefront Biotherapeutics NV

    ROE 16.3% with a current ratio of 30.5 on Healthcare exposure.

    1.78B EUR
  13. 13
    PGYPagaya Technologies Ltd.

    ROE 19.5% with a current ratio of 14.6 on Technology exposure.

    1.78B USD
  14. 14
    CMRECostamare Inc.

    ROE 16.0% with a current ratio of 1.6 on Industrials exposure.

    1.77B USD
  15. 15
    TPBTurning Point Brands, Inc.

    ROE 17.6% with a current ratio of 5.7 on Consumer Staples exposure.

    1.74B USD
  16. 16
    INSPInspire Medical Systems, Inc.

    ROE 18.0% with a current ratio of 8.6 on Healthcare exposure.

    1.74B USD
  17. 17
    EFCEllington Financial Inc.

    ROE 12.2% with a current ratio of 35.2 on Real Estate exposure.

    1.73B USD
  18. 18
    RVLVRevolve Group, Inc.

    ROE 14.3% with a current ratio of 2.5 on Consumer Discretionary exposure.

    1.73B USD
  19. 19
    EZPWEZCORP, Inc.

    ROE 14.7% with a current ratio of 4.8 on Financials exposure.

    1.71B USD
  20. 20
    TRINTrinity Capital Inc.

    ROE 12.9% with a current ratio of 2.0 on Financials exposure.

    1.71B USD
  21. 21
    PRGPROG Holdings, Inc.

    ROE 17.1% with a current ratio of 4.5 on Industrials exposure.

    1.71B USD
  22. 22
    BLFSBioLife Solutions, Inc.

    ROE 12.8% with a current ratio of 9.7 on Healthcare exposure.

    1.70B USD
  23. 23
    ANIPANI Pharmaceuticals, Inc.

    ROE 20.5% with a current ratio of 2.9 on Healthcare exposure.

    1.66B USD
  24. 24
    PWPPerella Weinberg Partners

    ROE 12.7% with a current ratio of 1.9 on Financials exposure.

    1.65B USD
  25. 25
    IDTIDT Corporation

    ROE 25.2% with a current ratio of 1.9 on Communication Services exposure.

    1.62B USD
Other top-25 lists